Should we be screening blood donors for hepatitis G virus? The case against screening

Medical Journal of Australia

Volumn 169, Issue 7, 1998, Pages 375-377

  Wong, Ping Yee ^a   Coghlan, Patrick J ^b   Angus, Peter W ^c  

^a Australian Red Cross   (Australia)

^b AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; HEPATITIS G VIRUS; HUMAN; SCREENING; SHORT SURVEY; VIRUS TRANSMISSION;

EID: 0032487605     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1998.tb126808.x     Document Type: Short Survey

References (32)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996; 334: 1685-1690.
2. Alter HJ. G-pers, creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus [editorial]. Transfusion 1997; 37: 569-572.
3. Holland PV. Viral infections and the blood supply [editorial]. N Engl J Med 1996; 334: 1734-1735.
4. Whyte GS. Is screening of Australian blood donors for HTLV-I necessary? Med J Aust 1997; 166: 478-481.
5. Shimizu M, Osada K, Okamoto H, Transmission of GB virus C by blood transfusions during heart surgery. Vox Sang 1997; 72: 76-78.
6. Heuft HG, Berg T, Schreier E, et al. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood. Vox Sang 1998; 74: 161-167.
7. Roth WK, Waschk D, Marx S, et al. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients. Transfusion 1997; 37:651-656.
8. Alter HJ, Nakatsuji Y, Melpolder J, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-754.
9. Simons JN, Desai SM, Mushahwar IK. The GB viruses: isolation, characterization, diagnosis, and epidemiology. Viral Hepatitis Reviews 1996; 2: 229-246.
10. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-1132.
11. Moaven LD, Locarnini SA, Bowden DS, et al. Hepatitis G virus and fulminant hepatic failure: evidence for transfusion related infection. J Hepatol 1997; 27: 613-619.
12. Goldstein NS, Underhill J, Gordon SC, et al. Comparative histologic features of liver biopsy specimens from patients coinfected with hepatitis G and C viruses with chronic hepatitic C virus alone An age-, sex-, disease duration-, and transmission-matched controlled study of chronic hepatitis. Am J Clin Pathol 1997; 108: 625-632.
13. Batts KP. Hepatitis G. A virus in search of a disease [editorial]. Am J Clin Pathol 1997; 108:616-618.
14. Viazov S, Riffelmann M, Sarr S, et al. Transmission of GBV-C/HGV from drug-addicted mothers to their babies. J Hepatol 1997; 27: 85-90.
15. Kao JH, Chen W, Chen PJ, et al. GB virus-C/hepatitis G virus infections in prostitutes: possible role of sexual transmission. J Med Virol 1997; 52: 381-384.
16. Yoshikawa A, Fukuda S, Itoh K, et al. Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C), among blood donors in Japan. Transfusion 1997; 37: 657-663.
17. Coghlan PJ, Wong P-Y Katsoris J, et al. Hepatitis G - issues for the blood bank [abstract]. Presentation at the Fourth National Symposium on Hepatitis C and Related Viruses Including Hepatitis G. 23 November 1996, St Vincent's Hospital, Melbourne, Australia.
18. Loiseau Mariotti M, Corbi C, et al. Prevalence of hepatitis G virus RNA in French blood donors and recipients. Transfusion 1997; 37: 645-650.
19. Wang Y, Chen H-S, Fan M-H, et al. Infection with GB virus C and hepatitis C virus in hemodialysis patients and blood donors in Beijing. J Med Virol 1997; 52: 26-30.
20. Bassil L, Kleter B, Ribeiro-dos-Santos G, et al. Hepatitis G virus: prevalence and sequence analysis in blood donors of Sao Paulo, Brazil. Vox Sang 1997; 74: 83-87.
21. Jarvis LM, Davidson F, Hanley JR et al. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352-1355.
22. Moaven LD, Hyland CA, Young IF, et al. Prevalence of hepatitis G virus in Queensland blood donors. Med J Aust 1996; 165: 369-371.
23. Dille BJ, Surowy TK, Gutierrez RA, et al. An ELISA for detection of antibodies to the E2 protein of GB virus C. J Infect Dis 1997; 175: 458-461.
24. Kao JH, Chen PJ, Chen W, et al Amplification of GB virus-C/hepatitis G virus RNA with primers from different regions of the viral genome. J Med Virol 1997; 51 : 284-289.
25. Whyte G. Quantitating donor behaviour to model the effect of changes in donor management on sufficiency in the blood service. Vox Sang. In press.
26. Busch MR. To thy (reactive) donors be true! Transfusion 1997; 37: 117-120.
27. National Health and Medical Research Council. Case study of screening blood donations for human T-cell lymphotropic virus type I (HTLV-I). Canberra: AGPS, 1993.
28. Di Bisceglie AM. Hepatitis G virus infection: a work in progress. Ann Intern Med 1996; 125: 772-773.
29. Allain J-P Screening blood donors for markers of new viruses [commentary]. Lancet 1997; 349: 584-585.
30. Karayiannis P, Thomas HC. Current status of hepatitis G virus (GBV-C) in transfusion: is it relevant? Vox Sang 1997; 73: 63-69,
31. Barbara JA. Does GB virus C ('hepatitis G virus') threaten the safety of our blood supply? [editorial]. Transf Med 1997; 7: 75-76.
32. Snyder EL, Lipton KS. Hepatitis G virus: status report and assessment of clinical relevance. MBB Association Bulletin 1998; Bulletin No 98-4, 18 July 1998.